Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
10
×
detroit blog main
10
×
detroit top stories
fda
10
×
life sciences
national blog main
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
indiana blog main
indiana top stories
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
national
cancer
drugs
eli lilly
cancer immunotherapy
deals
investing
nonalcoholic steatohepatitis
startups
teva pharmaceutical
vertex pharmaceuticals
abbvie
What
drug
10
×
fda
approved
roundup
approval
bio
cancer
new
won
annual
attention
biotech
class
companies
developed
drugs
medicine
medicines
meeting
migraine
news
nod
oral
patients
potential
prices
second
therapeutics
therapy
time
agency
ahead
aimmune
allergy
alzheimer’s
ambien
american
amgen
aren’t
arguments
Language
unset
Current search:
fda
×
drug
×
" detroit blog main "
×
" clinical trials "
×
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines